Policy Brief: Country Perspectives on Incentives
15.12.2020: In collaboration with the EU Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), the Global AMR R&D Hub publishes a policy brief “Incentivizing antibiotic access and innovation”. The brief presents the overall results from in-depth interviews with 13 countries – including 3 x outside of the EU. Findings include general support for antibiotic incentives, with the majority of interviewed countries preferring incentives that will secure access to both old and new antibiotics. Countries want more information on suitable multinational models and costs. Full manuscript is expected in 2021. Read the policy brief here.